Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
ALMS
ALMS News & Events
-
Add to Watchlist
Trade ALMS
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Forecast
Technical
Valuation
Financials
Earnings
Should I Buy
News
ALMS News
BML Capital Management Fully Exits Alumis Stake
5 days ago
Fool
Brookfield to Acquire Peakstone Realty Trust for $1.2 Billion
6 days ago
Benzinga
Analysts Bullish on Century Communities, Target Price Set at $92
Jan 21 2026
Benzinga
Alumis Director Srinivas Akkaraju Purchases 588,235 Shares for ~$10 Million
Jan 17 2026
Fool
Alumis (NASDAQ:ALMS) Acquires 588,235 Shares for $10 Million
Jan 17 2026
NASDAQ.COM
Activist Investors Target Staar Surgical, Alumis, and Other Stocks
Jan 17 2026
Barron's
Russell 2000 Kicks Off 2026 Strong, Surging Over 7% Year-to-Date
Jan 15 2026
Benzinga
Alumis Inc. (ALMS) Reports 65% PASI 90 Achievement for Envudeucitinib in Psoriasis Trials
Jan 14 2026
NASDAQ.COM
Show More News
ALMS Events
02/02 10:10
Alumis Stock Rises 7.8% to $26.43
Alumis is up 7.8%, or $1.92 to $26.43.
01/14 12:10
Alumis Stock Rises 10.2% to $24.37
Alumis is up 10.2%, or $2.26 to $24.37.
Show More Events
ALMS Monitor News
Alumis Inc. reaches 52-week high amid market gains
Jan 28 2026
Alumis Inc. shares surge after positive trial results for Envudeucitinib
Jan 06 2026
ALMS Earnings Analysis
No Data
People Also Watch
